IGC Pharma, Inc.

IGC

AMEX

Healthcare

Biotechnology

Potomac, MD, US67 employeesigcpharma.com

$0.27

-0.01(-1.8%)

52W $0.25 – $0.47

AI-generated

IGC Pharma, Inc.

Revenue breakdown: Plant And Cannabinoid (48.5%), Tolling White Labeling Service (39.1%), Wellness And Lifestyle (6.3%).

$26MMkt Cap

—Rev TTM

—NI TTM

Latest Earnings

10-Q

Q2 FY2026Nov 13, 2025

10-Q for Q2 FY2026 was filed on 2025-11-14. AI summary is not available yet.

Read full analysis View SEC Filing

What Changed Recently

Other Event

Mar 29, 2026

, including Exhibit 99.1, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor

View filing →

Material Agreement

Mar 11, 2026

Entry into a Material Definitive Agreement. On March 5, 2026, IGC Pharma, Inc. (“IGC” or the “Company”) entered into a Securities Purchase Agreement (the “Purch

View filing →

Material Agreement

Jan 5, 2026

Entry into a Material Definitive Agreement. On January 5, 2026, IGC Pharma, Inc. (“IGC” or the “Company”) entered into a Subscription Agreement (the “2025 Subsc

View filing →

View all recent events →

Fundamentals

How The Business Makes Money

Revenue by Segment

Plant And Cannabinoid48.5%($3M)

Tolling White Labeling Service39.1%($2M)

Wellness And Lifestyle6.3%($341.0K)

Infrastructure Segment3%($164.0K)

Other Revenue3%($164.0K)

Revenue by Geography

US93.6%($2M)

IN6.3%($164.0K)

CO0.2%($4.0K)

Analyst View

Peer Companies

Company	Price	Change	Market Cap	P/E
ANTXAN2 Therapeutics, Inc.	$3.29	-4.78%	$90M	-3.3
QTTBQ32 Bio Inc.	$6.45	+5.56%	$79M	2.8
NTRBNutriband Inc.	$3.75	+4.17%	$46M	-3.6
SABSSAB Biotherapeutics, Inc.	$3.88	+0.13%	$37M	5.7
NXTCNextCure, Inc.	$10.74	+1.99%	$29M	-0.7
PLURPluri Inc.	$3.32	-0.90%	$27M	-1.1
BOLDBoundless Bio, Inc.	$1.09	-3.54%	$24M	-0.4
INTSIntensity Therapeutics, I...	$5.66	-0.52%	$11M	-0.9

Company Profile

CIK0001326205

ISINUS45408X3089

CUSIP45408X308

Phone301 983 0998

Address10224 Falls Road, Potomac, MD, 20854, US

SEC EDGAR